Ovarian Germ Cell Cancer clinical trials
The registry lists 30 studies for Ovarian Germ Cell Cancer across more than 10 countries. 2 are recruiting or about to start. 6 of them are mainly about Ovarian Germ Cell Cancer (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.
Get an email when these change. Save the Ovarian Germ Cell Cancer studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Children's Oncology Group (8) · National Cancer Institute (NCI) (3) · Children's Cancer and Leukaemia Group (3) · National Institutes of Health Clinical Center (CC) (3) · Memorial Sloan Kettering Cancer Center (2) · Masonic Cancer Center, University of Minnesota (2) · Seagen Inc. (1) · Beihua Kong (1)
What is being tested here
Drugs under test in Ovarian Germ Cell Cancer studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Carboplatin | 1 | 1 | 7 |
| Paclitaxel | 1 | 1 | 3 |
| Etoposide | 0 | 1 | 6 |
| Ifosfamide | 0 | 0 | 3 |
| Thiotepa | 0 | 0 | 3 |
| Bleomycin | 0 | 1 | 3 |
| Filgrastim | 0 | 0 | 2 |
| Cisplatin | 0 | 1 | 2 |
| Temozolomide | 0 | 0 | 2 |
| Liposomal doxorubicin | 0 | 0 | 1 |
Drug classes tested here Antimitotic agents 1 open · Alkylating agents 8
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Apr 2027SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours · Imperial College London
Who these studies take
Of the 1 Ovarian Germ Cell Cancer studies recruiting now, 0 (0%) set no upper age limit and 1 (100%) stop at 75 or younger. 1 (100%) take children under 18. 1 (100%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 0 (0%) |
| 30 | 1 (100%) | 0 (0%) |
| 40 | 1 (100%) | 0 (0%) |
| 50 | 1 (100%) | 0 (0%) |
| 65 | 1 (100%) | 0 (0%) |
| 75 | 0 (0%) | 0 (0%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 30 studies, recruiting or not: 80% stop at 75 or younger and 77% at 65; 97% take children; 10% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 30 of 30. search them.
- SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell TumoursNot yet recruitingNCT06329323
- TC or BEP in Treating Patients With Malignant Ovarian Germ Cell TumorsRecruitingNCT02429687Phase 31 country
- Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsTerminatedNCT00788125Phase 1/21 country
- A Study of SGN-ALPV in Advanced Solid TumorsTerminatedNCT05229900Phase 15 countries
- Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 11 country
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyCompletedNCT00716976Phase 33 countries
- Autologous Peripheral Blood Stem Cell Transplant for Germ Cell TumorsCompletedNCT00432094Phase 21 country
- Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell TumorsCompletedNCT00053352Phase 36 countries
- Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 11 country
- DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or SiblingsCompletedNCT014343551 country
- Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell TumorsCompletedNCT00467051Phase 24 countries
- Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsTerminatedNCT00003926Phase 11 country
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT008974421 country
- Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal TumorsCompletedNCT01572467
- Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsCompletedNCT00024258Phase 21 country
- Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerTerminatedNCT01132547Phase 31 country
- Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 11 country
- Development of Strategies to Increase Enrollment in Clinical Trials for Children With CancerCompletedNCT000024854 countries
- Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationStatus unknownNCT00036712Phase 21 country
- Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell TumorsStatus unknownNCT00276718Not applicable2 countries
- Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell TumorsStatus unknownNCT00274950Phase 32 countries
- Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01Status unknownNCT004367742 countries
- Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell TumorsCompletedNCT00003811Phase 26 countries
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 21 country
- Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin LymphomaCompletedNCT00040911Not applicable1 country
- Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantCompletedNCT00569283Phase 11 country
- High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsCompletedNCT00003173Phase 21 country
- ABT-751 in Treating Young Patients With Refractory Solid TumorsCompletedNCT00036959Phase 11 country
- Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyCompletedNCT00030108Phase 11 country
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 11 country